Premenstrual Syndrome-PMS Clinical Trial
— AromatherapyOfficial title:
The Effect of Aromatherapy Application With Bergamot and Grapefruit Essential Oils on Premenstrual Syndrome and Menstrual Symptoms
Aromatherapy is;the science of using highly concentrated essential oils or essences distilled from plants to take advantage of their therapeutic properties. Essential oils or essences are obtained from various parts of plants (root, leaf, flower, bark, fruit) and used therapeutically for physical and psychological well-being. Premenstrual syndrome (PMS) is a health problem characterized by the periodic occurrence of physical, cognitive, emotional and behavioral symptoms during the luteal phase of the menstrual cycle, ending with the onset of menstruation or with the alleviation of symptoms within a few days after the onset of menstruation. It is reported that approximately 80-95% of women complain of PMS complaints. Although the use of aromatherapy in womens health is widespread, there is no study comparing bergamot and grapefruit essential oils. The aim of this study was to determine the effect of aromatherapy with bergamot and grapefruit essential oils on premenstrual syndrome and menstrual symptoms.
Status | Recruiting |
Enrollment | 90 |
Est. completion date | May 30, 2024 |
Est. primary completion date | April 20, 2024 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 18 Years to 35 Years |
Eligibility | Inclusion Criteria - To be between the ages of 18-35 - Experiencing at least 5 of the pms complaints (self-report) - Not having respiratory diseases such as asthma and bronchitis (self-report) - No pregnancy or suspected pregnancy (self-report) - Not being allergic to any substance (self-report) - Not having a systemic disease such as diabetes, hypertension (self-report) Exclusion Criteria: - Under 18, over 35 years of age Not experiencing pms complaints Finding anosmia Presence of respiratory system diseases Allergic symptoms to aromatherapy Being pregnantHaving a chronic disease |
Country | Name | City | State |
---|---|---|---|
Turkey | Ankara Medipol Universty | Ankara | Altindag |
Lead Sponsor | Collaborator |
---|---|
Esra ÖZER | KTO Karatay University |
Turkey,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Premenstrual syndrome scale (PMS) | It is a five-point Likert type scale consisting of 44 questions measuring the severity of premenstrual symptoms. A minimum of 44 and a maximum of 220 points can be obtained from the scale. An increase in the score obtained from the scale indicates that the intensity of PMS symptoms increases. In the PMS scale, PMS is considered to be "present" if it exceeds 50% (110) of the total scale score (220). | Baseline and three months later | |
Secondary | Menstrual Symptom Scale | Scale items are numbered according to the allocated factors for ease of use. 1-13. Items belong to the "Negative effects/somatic complaints" subscale, items 14-19. The items refer to the "Menstrual pain symptoms" subscale and items 20-22. The items belong to the "Coping methods" sub-dimension. Cronbach's Alpha value is 0.86. It is a five-point Likert type scale consisting of 22 items. The score obtained from the sub-dimensions is calculated by taking the total score average of the items in the sub-dimensions. Average score for sub-dimensions Its increase indicates that the severity of menstrual symptoms related to that sub-dimension increases. | Baseline and three months later |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT02402049 -
Homeopathic Treatment of Premenstrual Syndrome
|
Phase 3 |